Quasar Medical has acquired Medres' Nitinol Design and Development Center in San Diego, California, significantly expanding its Nitinol engineering, prototyping, precision processing, and manufacturing capabilities. The acquisition strengthens Quasar's global technology organization and enhances its ability to support complex medical device development from concept through commercialization.
San Diego, California | July 31, 2026
Quasar Medical has announced the acquisition of Medres' Nitinol Design and Development Center in San Diego, California, expanding its capabilities in advanced Nitinol design, development, and manufacturing.
The acquisition includes a 10,000-square-foot facility with specialized engineering talent, dedicated Nitinol operations, and precision manufacturing capabilities. The site will serve as Quasar's Nitinol Design and Development Center, strengthening its global technology organization under Christine Trepanier, Senior Vice President of Technology.
The center provides expertise in Nitinol component design, rapid prototyping, laser cutting, shape setting, electropolishing, process development, and precision manufacturing.
By integrating the San Diego team with its existing development and manufacturing network, Quasar is expanding its ability to support medical device OEMs earlier in the product lifecycle.
The acquisition also brings additional industry expertise to Quasar, including Tom Duerig, a pioneer in medical Nitinol technology, who joins as Senior Advisor.
The San Diego center will collaborate with Quasar's global engineering and manufacturing teams to support medical device applications requiring complex Nitinol components.
With complementary manufacturing operations in Tecate, Mexico, Quasar is strengthening the connection between early-stage innovation, process development, and commercial manufacturing for next-generation minimally invasive devices.
More information

